ABSTRACT
In western working-age populations, proliferative diabetic retinopathy is the leading cause of blindness and visual impairment. In order to learn more about “hypertension, dyslipidemia, and diabetic nephropathy” in “type 2 diabetic proliferative retinopathy,” researchers set out to conduct this study. The “cross-sectional study” was done at Karad’s Krishna Hospital from 2019–2021. Our OPD needed pre-registration. Hypertension, dyslipidemia, and nephropathy in proliferative diabetic retinopathy patients were noted upon registration. Assessment results were recorded. Proliferative diabetic retinopathy patients had hypertension, dyslipidemia, and diabetic nephropathy. 44 individuals were researched from December 2019–May 2021. Excel-compiled data Quantitative statistics were mean +/- SD, whereas qualitative data were percentages and proportions (%). (Min-Max). Results resembled. Chi-squared assessed quality. Independent student t-tests evaluated quantitative parameters between groups. The significance level was 0.05. The data from Open epi 2.3.1 were examined. Diabetes diagnosis and risk reduction need extensive surveys. Early retinopathy screening for diabetics is recommended. Counseling and avoiding noncompliant patients prevent sickness.
